Skip to main content

Table 2 Protein spots identified by Uniprot databases and MS analysis data set of the bladder cancer tissue samples

From: Comparative proteomics analysis in different stages of urothelial bladder cancer for identification of potential biomarkers: highlighted role for antioxidant activity

No

Protein name

Spot

No.

PI

Theoretical

MW [kDa]

NMIBC

1

Peroxiredoxin (PRDX1)

1

8.27

22,11

2

Pyrimidine nucleoside monophosphate kinase (UMP/CMPK)

3

5.44

22,22

3

Glutathione S-transferase M1 (GSTM1)

4

5.43

23,356

4

Phosphoglycerate mutase 1 (PGAM1)

5

6.67

28,804

5

Peroxiredoxin (PRDX6)

8

6

25,035

6

Proteasome activator complex subunit1 (PSME1)

9

5.78

28,723

7

Heat shock protein beta-1 (HSPB-1)

10

5.98

22,782

8

Annexin-I (ANXA1)

11

6.57

38,714

9

Macrophage-capping protein (CAPG)

12

5.82

38,498

MIBC

10

Biliverdin Reductase B (Flavin Reductase) (BLVRB)

2

7.13

22,119

11

Peroxiredoxin (PRDX2)

6

5.66

2,892

12

15-hydroxyprostaglandin dehydrogenase (HPGD)

7

5.56

28,977

  1. pI – isoelectric point; MW, molecular weight; non-muscle-invasive bladder cancer, NMIBC; muscle-invasive bladder cancer, MIBC.